Efficacy and safety of ertugliflozin in subjects with type 2 diabetes mellitus inadequately controlled on the dual combination of metformin and sitagliptin: the VERTIS SITA2 trial
被引:0
|
作者:
Lauring, B.
论文数: 0引用数: 0
h-index: 0
机构:
Merck & Co Inc, Rahway, NJ 07065 USAMerck & Co Inc, Rahway, NJ 07065 USA
Lauring, B.
[1
]
Eldor, R.
论文数: 0引用数: 0
h-index: 0
机构:
Merck & Co Inc, Rahway, NJ 07065 USAMerck & Co Inc, Rahway, NJ 07065 USA
Eldor, R.
[1
]
Liu, J.
论文数: 0引用数: 0
h-index: 0
机构:
Merck & Co Inc, Chicago, IL USAMerck & Co Inc, Rahway, NJ 07065 USA
Liu, J.
[2
]
Dagogo-Jack, S.
论文数: 0引用数: 0
h-index: 0
机构:
Univ Tennessee, Ctr Hlth Sci, Memphis, TN 38163 USAMerck & Co Inc, Rahway, NJ 07065 USA
Dagogo-Jack, S.
[3
]
Amorin, G.
论文数: 0引用数: 0
h-index: 0
机构:
MSD Argentina, Buenos Aires, DF, ArgentinaMerck & Co Inc, Rahway, NJ 07065 USA
Amorin, G.
[4
]
Johnson, J.
论文数: 0引用数: 0
h-index: 0
机构:
Merck & Co Inc, Rahway, NJ 07065 USAMerck & Co Inc, Rahway, NJ 07065 USA
Johnson, J.
[1
]
Hille, D.
论文数: 0引用数: 0
h-index: 0
机构:
Merck & Co Inc, Kenilworth, NJ USAMerck & Co Inc, Rahway, NJ 07065 USA
Hille, D.
[5
]
Huyck, S.
论文数: 0引用数: 0
h-index: 0
机构:
Merck & Co Inc, Rahway, NJ 07065 USAMerck & Co Inc, Rahway, NJ 07065 USA
Huyck, S.
[1
]
Golm, G.
论文数: 0引用数: 0
h-index: 0
机构:
Merck & Co Inc, Rahway, NJ 07065 USAMerck & Co Inc, Rahway, NJ 07065 USA
Golm, G.
[1
]
Terra, S.
论文数: 0引用数: 0
h-index: 0
机构:
Pfizer Inc, Andover, MA USAMerck & Co Inc, Rahway, NJ 07065 USA
Terra, S.
[6
]
Mancuso, J.
论文数: 0引用数: 0
h-index: 0
机构:
Pfizer Inc, Groton, CT 06340 USAMerck & Co Inc, Rahway, NJ 07065 USA
Mancuso, J.
[7
]
Engel, S. S.
论文数: 0引用数: 0
h-index: 0
机构:
Merck & Co Inc, Rahway, NJ 07065 USAMerck & Co Inc, Rahway, NJ 07065 USA
Engel, S. S.
[1
]
机构:
[1] Merck & Co Inc, Rahway, NJ 07065 USA
[2] Merck & Co Inc, Chicago, IL USA
[3] Univ Tennessee, Ctr Hlth Sci, Memphis, TN 38163 USA